Cannabinoid Receptor 2-Centric Molecular Feedback Loop Drives Necroptosis in Diabetic Heart Injuries

Area of Science:

• Cardiovascular Biology
• Metabolic Disease Research
• Cell Death Mechanisms

Background:

• Diabetic heart dysfunction is a significant complication of diabetes, primarily driven by cell death.
• The precise timing and sequence of cell death pathways in diabetic hearts remain poorly understood.
• Identifying specific cell death types and therapeutic intervention points is crucial for treating diabetic cardiomyopathy.

Purpose of the Study:

• To identify the specific cell death pathway responsible for diabetic heart dysfunction.
• To elucidate the molecular mechanisms regulating this cell death pathway.
• To propose a novel therapeutic strategy targeting this pathway for diabetic heart disease.

Main Methods:

• Utilized type 1 and type 2 diabetic mouse models (db/db, HFD/STZ, STZ-induced).
• Assessed apoptosis and necroptosis in diabetic mouse hearts across different ages.
• Employed G protein-coupled receptor drug libraries, pharmacological/genetic modulation, stable cell lines, and custom phosphorylation antibodies for mechanistic studies.

Main Results:

• Necroptosis was activated post-apoptosis in later stages of diabetes and directly caused cardiac dysfunction.
• Cannabinoid Receptor 2 (CB2R) was identified as a key regulator of necroptosis.
• CB2R normally represses necroptosis via BACH2; high glucose disrupts this by promoting CB2R internalization and subsequent MLKL-mediated phosphorylation and degradation of CB2R, creating a feedback loop.

Conclusions:

• A novel molecular regulatory loop involving CB2R and BACH2 controls necroptosis in the diabetic heart.
• CB2R activation represses necroptosis, while MLKL activation leads to CB2R phosphorylation and degradation, forming a negative feedback mechanism.
• Targeting the CB2R-centered necroptosis pathway presents a promising therapeutic strategy for diabetic heart dysfunction.